Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults
Clinical trial NCT04629131 · COMPLETED
Trial details
- NCT number
- NCT04629131
- Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-25
- Primary completion
- 2021-08-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.